{"paper_id":"43566f83-c4c3-4015-a73c-f316b42f5a7f","body_text":"Abstract\nEndometriosis is defined as the presence of endometrial-type mucosa outside the uterine cavity. Several theories have been proposed during the last 20 years to explain the disease pathogenesis; however, a unique consensus has not yet been established. Although the most recent pathogenic theory is based on inflammatory causes [1], hormonal influence is certainly involved not only in the endometriosis pathogenesis but also in its development and progression [2].\nAccess this chapter\nTax calculation will be finalised at checkout\nPurchases are for personal use only\nSimilar content being viewed by others\nReferences\nSourial S, Tempest N, Hapangama DK. Theories on the pathogenesis of endometriosis. Int J Reprod Med. 2014;2014:179515.\nDi Guardo F, et al. Management of women affected by endometriosis: are we stepping forward? J Endo Pelvic Pain Dis. 2019;11(2):77–84.\nRoy D, et al. Integrated bioinformatics, environmental epidemiologic and genomic approaches to identify environmental and molecular links between endometriosis and breast Cancer. Int J Mol Sci. 2015;16(10):25285–322.\nPreciados M, et al. Estrogenic endocrine disrupting chemicals influencing NRF1 regulated gene networks in the development of complex human brain disease. Int J Mol Sci. 2016;17(12):2086.\nWelshons WV, et al. Large effects from small exposures. I. Mechanisms for endocrine-disrupting chemicals with estrogenic activity. Environ Health Perspect. 2003;111(8):994–1006.\nBorgeest C, et al. The effects of endocrine disrupting chemicals on the ovary. Front Biosci. 2002;7:d1941–8.\nZoeller RT, et al. Endocrine-disrupting chemicals and public health protection: a statement of principles from the Endocrine Society. Endocrinology. 2012;153(9):4097–110.\nStreet ME, et al. Current knowledge on endocrine disrupting chemicals (EDCs) from animal biology to humans, from pregnancy to adulthood: highlights from a national Italian meeting. Int J Mol Sci. 2018;19(6):1647.\nSkinner MK. Endocrine disruptors in 2015: epigenetic transgenerational inheritance. Nat Rev Endocrinol. 2016;12(2):68–70.\nCraig ZR, et al. Endocrine-disrupting chemicals in ovarian function: effects on steroidogenesis, metabolism and nuclear receptor signaling. Reproduction. 2011;142(5):633–46.\nLi X, Frank AA. Improvement of bisphenol A quantitation from urine by LCMS. Anal Bioanal Chem. 2015;407(13):3869–74.\nKim JH. Analysis of the in vitro effects of di-(2-ethylhexyl) phthalate exposure on human uterine leiomyoma cells. Exp Ther Med. 2018;15(6):4972–8.\nGermaine M, et al. Bisphenol A and phthalates and endometriosis, the ENDO study. Fertil Steril. 2013;100(1):162–9.\nMichalowicz J. Bisphenol A-sources toxicity and biotransformation. Environ Toxicol Pharmacol. 2014;37(2):738–58.\nLi Y, et al. Differential in vitro biological action, coregulator interactions, and molecular dynamic analysis of bisphenol A (BPA), BPAF, and BPS ligand-ERa complexes. Environ Health Perspect. 2018;126(1):017012.\nWatson CS, et al. Nongenomic signaling pathways of estrogen toxicity. Toxicol Sci. 2010;115(1):1–11.\nXu J, et al. Developmental Bisphenol A exposure modulates immune-related diseases. Toxics. 2016;4(4):23.\nNorth ML, et al. Effects of phthalates on the development and expression of allergic disease and asthma. Ann Allergy Asthma Immunol. 2014;112(6):496–502.\nOkubo T, et al. Estimation of estrogenic and anti-estrogenic activities of some phthalate diesters and monoesters by MCF-7 cell proliferation assay in vitro. Biol Pharm Bull. 2003;26:1219–24.\nFerguson KK, et al. Associations between maternal biomarkers of phthalate exposure and inflammation using repeated measurements across pregnancy. PLoS One. 2015;10(8):90135601.\nUpson K, et al. Organochlorine pesticides and risk of endometriosis: findings from a population-based case-control study. Environ Health Perspect. 2013;121(11–12):1319–24.\nIgarashi T, et al. Expression of Ah receptor and dioxin-related genes in human uterine endometrium in women with or without endometriosis. Endocr J. 1999;46:765–72.\nBruner-Tran KL, et al. Dioxin may promote inflammation-related development of endometriosis. Fertil Steril. 2008;89(5 Suppl):1287–98.\nMissmer SA, et al. In utero exposures and the incidence of endometriosis. Fertil Steril. 2004;82(6):1501–8.\nAldad TS, et al. Bisphenol-A exposure alters endometrial progesterone receptor expression in the nonhuman primate. Fertil Steril. 2011;96(1):175–9.\nCho YJ, Park SB, Han M. Di-(2-ethylhexyl)-phthalate induces oxidative stress in human endometrial stromal cells in vitro. Mol Cell Endocrinol. 2015;407:9–17.\nSignorile PG, et al. Pre-natal exposure of mice to bisphenol A elicits an endometriosis-like phenotype in female offspring. Gen Comp Endocrinol. 2010;168(3):318–25.\nCobellis L, et al. High plasma concentrations of di-(2-ethylhexyl)-phthalate in women with endometriosis. Hum Reprod. 2003;18(7):1512–5.\nKim SH, et al. Increased plasma levels of phthalate esters in women with advanced-stage endometriosis: a prospective case-control study. Fertil Steril. 2011;95(1):357–9.\nCobellis L, et al. Measurement of bisphenol A and bisphenol B levels in human blood sera from healthy and endometriotic women. Biomed Chromatogr. 2009;23(11):1186–9.\nWeuve J, et al. Association of exposure to phthalates with endometriosis and uterine leiomyomata: findings from NHANES, 1999–2004. Environ Health Perspect. 2010;118(6):825–3.\nLouis B, et al. Bisphenol A and phthalates and endometriosis, the ENDO study. Fertil Steril. 2013;100(1):162–169.e2.\nItoh H, et al. Urinary bisphenol-A concentration in infertile Japanese women and its association with endometriosis: a cross-sectional study. Environ Health Prev Med. 2007;12:258–64.\nUpson K, et al. A population-based case-control study of urinary bisphenol A concentration and risk of endometriosis. Hum Reprod. 2014;29(11):2457–64.\nRashidi BH. A case-control study of Bisphenol A and endometrioma among subgroup of Iranian women. J Res Med Sci. 2017;22:7.\nAuthor information\nAuthors and Affiliations\nCorresponding author\nEditor information\nEditors and Affiliations\nRights and permissions\nCopyright information\n© 2021 International Society of Gynecological Endocrinology\nAbout this chapter\nCite this chapter\nPalumbo, M., Di Guardo, F. (2021). Endocrine Disruptors and Endometriosis Risk. In: Genazzani, A.R., Nisolle, M., Petraglia, F., Taylor, R.N. (eds) Endometriosis Pathogenesis, Clinical Impact and Management. ISGE Series. Springer, Cham. https://doi.org/10.1007/978-3-030-57866-4_1\nDownload citation\nDOI: https://doi.org/10.1007/978-3-030-57866-4_1\nPublished:\nPublisher Name: Springer, Cham\nPrint ISBN: 978-3-030-57865-7\nOnline ISBN: 978-3-030-57866-4\neBook Packages: MedicineMedicine (R0)","source_license":"CC0","license_restricted":false}